Statistics

Total Visits

Views
Response to cabazitaxel in patients with metastatic castrationresistant prostate cancer (mCRPC) poorly responding to docetaxel6

Select a period of time:

Number of views in the range

Views
Response to cabazitaxel in patients with metastatic castrationresistant prostate cancer (mCRPC) poorly responding to docetaxel4

Views

Views
December 20230
January 20241
February 20240
March 20241
April 20240
May 20242
June 20240
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States4
 

Top cities views

Views
Boardman1